SHIRE HUMAN GENETIC THERAPIES, INC. sold 6.82M shares of TRANSLATE BIO, INC. on the open market
Open‑market sale worth $141.14M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/30/2020ACC: 0001395064-20-000122
10% Owner
Since Jul 2018
-6.82M
Net shares
Net seller
$141.14M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.82M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.82M
Price / share
$20.68
Trade value
$141.14M
% of position
New position
6/30/2020
6.82M→0.00
Total
Net shares
−6.82M
Net value
-$141.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | S · Sale | −6.82M | $20.68 | $141.14M | New position | 6.82M | 0.00 |
| Total | −6.82M | -$141.14M | ||||||
Derivative Transactions0
No derivative transactions reported